Swedish Orphan Biovitrum AB (publ) (ST:SOBI) — Stock Price

Skr450.40 SEK
▼ -0.62% today

Swedish Orphan Biovitrum AB (publ) (ST:SOBI) is currently trading at Skr450.40 SEK, down 0.62% today. Over the past 52 weeks, shares have ranged between Skr268.00 and Skr480.00. This page tracks Swedish Orphan Biovitrum AB (publ)'s live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Swedish Orphan Biovitrum AB (publ) stock valuation.

Swedish Orphan Biovitrum AB (publ) (SOBI) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Swedish Orphan Biovitrum AB (publ)'s daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Swedish Orphan Biovitrum AB (publ) Income Statement — Revenue, Profit & Earnings by Year

Swedish Orphan Biovitrum AB (publ)'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr28.24 Billion Skr26.03 Billion Skr22.12 Billion Skr18.79 Billion Skr15.53 Billion
Cost of Revenue Skr15.92 Billion Skr5.79 Billion Skr5.00 Billion Skr4.78 Billion Skr3.48 Billion
Gross Profit Skr12.32 Billion Skr20.24 Billion Skr17.13 Billion Skr14.01 Billion Skr12.04 Billion
Research & Development Skr3.25 Billion Skr3.54 Billion Skr2.80 Billion Skr2.35 Billion Skr1.99 Billion
SG&A Skr11.14 Billion Skr7.55 Billion Skr10.16 Billion Skr7.85 Billion Skr6.29 Billion
Total Operating Expenses Skr4.27 Billion Skr14.62 Billion Skr13.06 Billion Skr10.17 Billion Skr8.26 Billion
Operating Income Skr8.05 Billion Skr5.62 Billion Skr4.07 Billion Skr3.81 Billion Skr3.73 Billion
EBITDA Skr10.96 Billion Skr9.30 Billion Skr7.23 Billion Skr6.05 Billion Skr5.71 Billion
EBIT Skr867.00 Million Skr5.62 Billion Skr4.07 Billion Skr3.78 Billion Skr3.71 Billion
Interest Expense Skr831.00 Million Skr1.24 Billion Skr1.11 Billion Skr459.00 Million Skr419.00 Million
Income Before Tax Skr34.00 Million Skr4.41 Billion Skr2.95 Billion Skr3.32 Billion Skr3.29 Billion
Income Tax Expense Skr-442.00 Million Skr528.00 Million Skr546.00 Million Skr683.00 Million Skr616.00 Million
Net Income Skr478.00 Million Skr3.88 Billion Skr2.41 Billion Skr2.64 Billion Skr2.68 Billion

Swedish Orphan Biovitrum AB (publ) Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Swedish Orphan Biovitrum AB (publ)'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr67.43 Billion Skr75.44 Billion Skr74.03 Billion Skr52.50 Billion Skr48.66 Billion
Total Current Assets Skr14.53 Billion Skr13.16 Billion Skr12.67 Billion Skr11.21 Billion Skr8.78 Billion
Cash & Equivalents Skr1.04 Billion Skr1.14 Billion Skr904.00 Million Skr1.36 Billion Skr1.04 Billion
Short-term Investments — Skr130.00 Million — Skr-9.00 Million Skr-9.00 Million
Net Receivables Skr8.36 Billion Skr7.38 Billion Skr7.06 Billion Skr6.14 Billion Skr4.11 Billion
Inventory Skr5.13 Billion Skr4.16 Billion Skr3.87 Billion Skr3.33 Billion Skr3.42 Billion
Property, Plant & Equipment Skr1.63 Billion Skr1.58 Billion Skr1.30 Billion Skr274.00 Million Skr493.00 Million
Goodwill Skr9.02 Billion Skr10.46 Billion Skr9.64 Billion Skr7.01 Billion Skr6.29 Billion
Total Liabilities Skr29.71 Billion Skr35.15 Billion Skr40.16 Billion Skr25.97 Billion Skr25.46 Billion
Total Current Liabilities Skr16.07 Billion Skr12.60 Billion Skr19.09 Billion Skr14.86 Billion Skr8.76 Billion
Long-term Debt Skr5.18 Billion Skr12.41 Billion Skr11.36 Billion Skr2.97 Billion Skr8.78 Billion
Net Debt Skr10.71 Billion Skr15.60 Billion Skr19.58 Billion Skr7.74 Billion Skr9.86 Billion
Total Stockholder Equity Skr37.72 Billion Skr40.29 Billion Skr33.87 Billion Skr26.52 Billion Skr23.20 Billion
Retained Earnings Skr22.40 Billion Skr21.92 Billion Skr18.05 Billion Skr15.79 Billion Skr13.15 Billion

Swedish Orphan Biovitrum AB (publ) Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Swedish Orphan Biovitrum AB (publ) generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr8.56 Billion Skr7.39 Billion Skr4.47 Billion Skr4.67 Billion Skr5.47 Billion
Capital Expenditures Skr40.00 Million Skr3.00 Billion Skr4.94 Billion Skr1.48 Billion Skr370.00 Million
Free Cash Flow Skr8.52 Billion Skr4.38 Billion Skr-473.00 Million Skr3.19 Billion Skr5.10 Billion
Investing Cash Flow Skr-4.29 Billion Skr-3.09 Billion Skr-21.90 Billion Skr-1.48 Billion Skr-367.00 Million
Financing Cash Flow Skr-4.32 Billion Skr-4.00 Billion Skr17.01 Billion Skr-2.99 Billion Skr-4.47 Billion
Dividends Paid — — — — —
Stock-Based Compensation Skr250.00 Million Skr218.00 Million Skr298.00 Million Skr268.00 Million Skr154.00 Million
Depreciation Skr10.10 Billion Skr3.68 Billion Skr3.17 Billion Skr2.42 Billion Skr2.01 Billion
Change in Cash Skr-99.00 Million Skr236.00 Million Skr-457.00 Million Skr316.00 Million Skr641.00 Million

Swedish Orphan Biovitrum AB (publ) Earnings History — EPS Actual vs. Analyst Estimates

Track Swedish Orphan Biovitrum AB (publ)'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 16, 2026 — 3.22 —
Apr 27, 2026 3.77 3.51 +7.41%
Feb 05, 2026 5.65 11.45 -50.66%
Oct 20, 2025 6.05 4.99 +21.24%
Jul 16, 2025 2.36 1.61 +46.58%
Apr 29, 2025 2.72 1.94 +40.21%
Feb 05, 2025 4.02 3.16 +27.22%
Oct 24, 2024 4.31 2.17 +98.62%